Finek J - Search Results

1

Prognostic Significance of Serum Tumor Markers in Patients with Advanced-stage NSCLC Treated with Pemetrexed-based Chemotherapy.

Fiala O, Pesek M, Finek J, Svaton M, Sorejs O, Bortlicek Z, Kucera R, Topolcan O. Fiala O, et al. Among authors: finek j. Anticancer Res. 2016 Jan;36(1):461-6. Anticancer Res. 2016. PMID: 26722082

2

The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence.

Holubec L Jr, Topolcan O, Pikner R, Pecen L, Vaclavickova J, Wirthova M, Molacek J, Stieber P, Holdenrieder S, Sen LH, Finek J. Holubec L Jr, et al. Among authors: finek j. Anticancer Res. 2000 Nov-Dec;20(6D):5237-44. Anticancer Res. 2000. PMID: 11326702

3

Criteria for the selection of referential groups in tumor marker statistical evaluation on the basis of a retrospective study.

Holubec L Jr, Topolcan O, Pikner R, Pecen L, Holubec Sen L, Finek J, Ludvikova M, Cerna M. Holubec L Jr, et al. Among authors: finek j. Anticancer Res. 2003 Mar-Apr;23(2A):865-70. Anticancer Res. 2003. PMID: 12820315

4

[Clinical importance of determination of tumor markers during follow-up in breast carcinoma].

Fínek J, Holubec L Jr, Topolcan O, Pikner R, Sůvová B, Treska V. Fínek J, et al. Cas Lek Cesk. 2004;143(3):174-7. Cas Lek Cesk. 2004. PMID: 15134036 Czech.

5

[Clinical relevance of tumor markers in epithelial ovarian cancer].

Holubec L Jr, Fínek J, Topolcan O, Bouda J, Rokyta Z. Holubec L Jr, et al. Among authors: finek j. Ceska Gynekol. 2004 May;69(3):225-8. Ceska Gynekol. 2004. PMID: 15309999 Czech.

6

[Serum tumor markers at exocrine adenocarcinoma of pancreas].

Holubec L, Finek J, Topolcan O, Svobodová S. Holubec L, et al. Among authors: finek j. Cas Lek Cesk. 2005;144(2):86-8; discussion 89. Cas Lek Cesk. 2005. PMID: 15807292 Review. Czech.

7

TPS, thymidine kinase, VEGF and endostatin in cytosol of thyroid tissue samples.

Pikner R, Ludvíkova M, Ryska A, Kholova I, Holubec L Jr, Topolcan O, Pecen L, Fínek J. Pikner R, et al. Among authors: finek j. Anticancer Res. 2005 May-Jun;25(3A):1517-21. Anticancer Res. 2005. PMID: 16033053 Free article.

8

Markers of cellular adhesion in diagnosis and therapy control of colorectal carcinoma.

Holubec L Jr, Topolcan O, Finek J, Holdenrieder S, Stieber P, Pesta M, Pikner R, Holubec Sen L, Sutnar A, Liska V, Svobodova S, Visokai V, Kormunda S. Holubec L Jr, et al. Among authors: finek j. Anticancer Res. 2005 May-Jun;25(3A):1597-601. Anticancer Res. 2005. PMID: 16033066 Free article.

9

Circulating nucleosomes and cytokeratin 19-fragments in patients with colorectal cancer during chemotherapy.

Holdenrieder S, Holubec L Jr, Topolcan O, Finek J, Stieber P. Holdenrieder S, et al. Among authors: finek j. Anticancer Res. 2005 May-Jun;25(3A):1795-801. Anticancer Res. 2005. PMID: 16033102 Free article.

10

Changes of thymidine kinase (TK) during adjuvant and palliative chemotherapy.

Topolcan O, Holubec L Jr, Finek J, Stieber P, Holdenrieder S, Lamerz R, Holubec Sen L, Svobodova S, Visokai V, Lipska L. Topolcan O, et al. Among authors: finek j. Anticancer Res. 2005 May-Jun;25(3A):1831-3. Anticancer Res. 2005. PMID: 16033109 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters